Synergistic infection with murine cytomegalovirus and Pseudomonas aeruginosa in mice
- PMID: 207792
- DOI: 10.1093/infdis/137.6.775
Synergistic infection with murine cytomegalovirus and Pseudomonas aeruginosa in mice
Abstract
A previous report from this laboratory demonstrated that mice infected intraperitoneally with a 0--20% lethal inoculum of murine cytomegalovirus (CMV) exhibited markedly enhanced mortality rates (90%--100%) within 48 hr after an intravenous injection of a 0--20% lethal inoculum of Pseudomonas aeruginosa. The current study demonstrated that mice infected with murine CMV alone had high titers of virus in multiple organs over a 20-day period, whereas mice injected with P. aeruginosa alone had a self-limited infection confined to the kidney. In the combined murine CMV-P. aeruginosa infection, titers of virus in tissues were changed very little. In contrast, P. aeruginosa was recovered in high concentrations from multiple organs, a finding which demonstrated a progressive systemic infection closely resembling that produced by a 100% lethal inoculum of P. aeruginosa alone in normal mice. An increased mortality rate due to P. aeruginosa in murine CMV-infected mice was dependent on inoculation of live bacteria and could not be explained by enhanced susceptibility to endotoxin. These results indicate that murine CMF markedly enhanced the suceptibility of mice to infection with P. aeruginosa and suggest that the virus altered mechanisms of host resistance important in recovery from bacterial infections.
Similar articles
-
Synergistic infection with murine cytomegalovirus and Candida albicans in mice.J Infect Dis. 1977 Jun;135(6):918-24. doi: 10.1093/infdis/135.6.918. J Infect Dis. 1977. PMID: 193998
-
Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections.Infect Immun. 1976 Oct;14(4):982-9. doi: 10.1128/iai.14.4.982-989.1976. Infect Immun. 1976. PMID: 186411 Free PMC article.
-
Murine cytomegalovirus-Pseudomonas synergistic infections: comparison of virulent and attenuated virus.Can J Microbiol. 1987 Oct;33(10):923-7. doi: 10.1139/m87-161. Can J Microbiol. 1987. PMID: 2825950
-
Reduced expression of gamma interferon in serum and marked lymphoid depletion induced by Porphyromonas gingivalis increase murine morbidity and mortality due to cytomegalovirus infection.Infect Immun. 2004 Oct;72(10):5791-8. doi: 10.1128/IAI.72.10.5791-5798.2004. Infect Immun. 2004. PMID: 15385479 Free PMC article.
-
Experimental murine cytomegalovirus infection of ocular structures.Arch Ophthalmol. 1984 Aug;102(8):1214-9. doi: 10.1001/archopht.1984.01040030984032. Arch Ophthalmol. 1984. PMID: 6087775
Cited by
-
Murine cytomegalovirus-induced immunosuppression.Infect Immun. 1982 Apr;36(1):89-95. doi: 10.1128/iai.36.1.89-95.1982. Infect Immun. 1982. PMID: 6281194 Free PMC article.
-
The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.Arch Virol. 1979;62(1):1-29. doi: 10.1007/BF01314900. Arch Virol. 1979. PMID: 231945 Review. No abstract available.
-
A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle.Can J Comp Med. 1982 Jul;46(3):225-63. Can J Comp Med. 1982. PMID: 6290011 Free PMC article. Review.
-
Animal viruses of economic importance: genetic variation, persistence, and prospects for their control.Pharmacol Ther. 1985;30(2):115-226. doi: 10.1016/0163-7258(85)90033-6. Pharmacol Ther. 1985. PMID: 3939479 Free PMC article. Review. No abstract available.
-
Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.Antiviral Res. 2011 Jun;90(3):151-9. doi: 10.1016/j.antiviral.2011.03.179. Epub 2011 Mar 23. Antiviral Res. 2011. PMID: 21439328 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources